Back to Report Store Home

Optic Nerve Disorders Drug Development Pipeline Review, 2018

  • Published: Oct-2018
  • Report Code: GBIHC049IDB
  • Report Format: pdf

Description

List of Tables

Table 1: Number of Products under Development for Optic Neuropathy

Table 2: Number of Products under Development by Companies, Optic Neuropathy

Table 3: Number of Products under Development by Universities/Institutes, Optic Neuropathy

Table 4: Products under Development by Companies, Optic Neuropathy

Table 5: Products under Development by Universities/Institutes, Optic Neuropathy

Table 6: Number of Products under Development for Glaucoma

Table 7: Number of Products under Development by Companies, Glaucoma

Table 8: Number of Products under Development by Universities/Institutes, Glaucoma

Table 9: Products under Development by Companies, Glaucoma

Table 10: Products under Development by Universities/Institutes, Glaucoma

Table 11: Number of Products under Development for Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)

Table 12: Number of Products under Development by Companies, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)

Table 13: Number of Products under Development by Universities/Institutes, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)

Table 14: Products under Development by Companies, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)

Table 15: Products under Development by Universities/Institutes, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)

Table 16: Number of Products under Development for Optic Neuritis

Table 17: Number of Products under Development by Companies, Optic Neuritis

Table 18: Number of Products under Development by Universities/Institutes, Optic Neuritis

Table 19: Products under Development by Companies, Optic Neuritis

Table 20: Products under Development by Universities/Institutes, Optic Neuritis

Table 21: Number of Products by Stage and Target, Optic Neuropathy

Table 22: Number of Products by Stage and Mechanism of Action, Optic Neuropathy

Table 23: Number of Products by Stage and Route of Administration, Optic Neuropathy

Table 24: Number of Products by Stage and Molecule Type, Optic Neuropathy

Table 25: Number of Products by Stage and Target, Glaucoma

Table 26: Number of Products by Stage and Mechanism of Action, Glaucoma

Table 27: Number of Products by Stage and Route of Administration, Glaucoma

Table 28: Number of Products by Stage and Molecule Type, Glaucoma

Table 29: Number of Products by Stage and Target, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)

Table 30: Number of Products by Stage and Mechanism of Action, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)

Table 31: Number of Products by Stage and Route of Administration, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)

Table 32: Number of Products by Stage and Molecule Type, Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy)

Table 33: Number of Products by Stage and Target, Optic Neuritis

Table 34: Number of Products by Stage and Mechanism of Action, Optic Neuritis

Table 35: Number of Products by Stage and Route of Administration, Optic Neuritis

Table 36: Number of Products by Stage and Molecule Type, Optic Neuritis

Table 37: Optic Neuropathy – Pipeline by Amgen Inc, H2 2018

Table 38: Optic Neuropathy – Pipeline by Ironwood Pharmaceuticals Inc, H2 2018

Table 39: Optic Neuropathy – Pipeline by Quark Pharmaceuticals Inc, H2 2018

Table 40: Optic Neuropathy – Pipeline by Regenera Pharma Ltd, H2 2018

Table 41: Optic Neuropathy – Pipeline by Regeneron Pharmaceuticals Inc, H2 2018

Table 42: Glaucoma – Pipeline by AC Immune SA, H2 2018

Table 43: Glaucoma – Pipeline by Aerie Pharmaceuticals Inc, H2 2018

Table 44: Glaucoma – Pipeline by Allergan Plc, H2 2018

Table 45: Glaucoma – Pipeline by Altacor Ltd, H2 2018

Table 46: Glaucoma – Pipeline by Amarantus Bioscience Holdings Inc, H2 2018

Table 47: Glaucoma – Pipeline by Amgen Inc, H2 2018

Table 48: Glaucoma – Pipeline by Annexon Inc, H2 2018

Table 49: Glaucoma – Pipeline by Astellas Pharma Inc, H2 2018

Table 50: Glaucoma – Pipeline by Bial - Portela & Ca SA, H2 2018

Table 51: Glaucoma – Pipeline by BioAxone BioSciences Inc, H2 2018

Table 52: Glaucoma – Pipeline by Can-Fite BioPharma Ltd, H2 2018

Table 53: Glaucoma – Pipeline by Cellix Bio Pvt Ltd, H2 2018

Table 54: Glaucoma – Pipeline by Certa Therapeutics Pty Ltd, H2 2018

Table 55: Glaucoma – Pipeline by Chong Kun Dang Pharmaceutical Corp, H2 2018

Table 56: Glaucoma – Pipeline by D. Western Therapeutics Institute Inc, H2 2018

Table 57: Glaucoma – Pipeline by Disarm Therapeutics Inc, H2 2018

Table 58: Glaucoma – Pipeline by Dompe Farmaceutici SpA, H2 2018

Table 59: Glaucoma – Pipeline by Elsalys Biotech SA, H2 2018

Table 60: Glaucoma – Pipeline by EyePoint Pharmaceuticals Inc, H2 2018

Table 61: Glaucoma – Pipeline by Eyevensys SAS, H2 2018

Table 62: Glaucoma – Pipeline by Fortress Biotech Inc, H2 2018

Table 63: Glaucoma – Pipeline by Gene Signal International SA, H2 2018

Table 64: Glaucoma – Pipeline by Glaukos Corp, H2 2018

Table 65: Glaucoma – Pipeline by Graybug Vision Inc, H2 2018

Table 66: Glaucoma – Pipeline by Han Wha Pharma Co Ltd, H2 2018

Table 67: Glaucoma – Pipeline by Handok Inc, H2 2018

Table 68: Glaucoma – Pipeline by HitGen LTD, H2 2018

Table 69: Glaucoma – Pipeline by ID Pharma Co Ltd, H2 2018

Table 70: Glaucoma – Pipeline by InMed Pharmaceuticals Inc, H2 2018

Table 71: Glaucoma – Pipeline by Inspyr Therapeutics Inc, H2 2018

Table 72: Glaucoma – Pipeline by Isarna Therapeutics GmbH, H2 2018

Table 73: Glaucoma – Pipeline by Kowa Co Ltd, H2 2018

Table 74: Glaucoma – Pipeline by Kukje Pharmaceutical Industry Co Ltd, H2 2018

Table 75: Glaucoma – Pipeline by Laboratorios SALVAT SA, H2 2018

Table 76: Glaucoma – Pipeline by Laboratorios Sophia SA de CV, H2 2018

Table 77: Glaucoma – Pipeline by Lee's Pharmaceutical Holdings Ltd, H2 2018

Table 78: Glaucoma – Pipeline by MimeTech Srl, H2 2018

Table 79: Glaucoma – Pipeline by Nemus Bioscience Inc, H2 2018

Table 80: Glaucoma – Pipeline by Neurim Pharmaceuticals Ltd, H2 2018

Table 81: Glaucoma – Pipeline by NicOx SA, H2 2018

Table 82: Glaucoma – Pipeline by NoNO Inc, H2 2018

Table 83: Glaucoma – Pipeline by Novaliq GmbH, H2 2018

Table 84: Glaucoma – Pipeline by Novartis AG, H2 2018

Table 85: Glaucoma – Pipeline by Ocular Therapeutix Inc, H2 2018

Table 86: Glaucoma – Pipeline by Oculis ehf, H2 2018

Table 87: Glaucoma – Pipeline by Ohr Pharmaceutical Inc, H2 2018

Table 88: Glaucoma – Pipeline by Oncolys BioPharma Inc, H2 2018

Table 89: Glaucoma – Pipeline by Pivot Pharmaceuticals Inc, H2 2018

Table 90: Glaucoma – Pipeline by Profarma, H2 2018

Table 91: Glaucoma – Pipeline by Q BioMed Inc, H2 2018

Table 92: Glaucoma – Pipeline by Quark Pharmaceuticals Inc, H2 2018

Table 93: Glaucoma – Pipeline by Regeneron Pharmaceuticals Inc, H2 2018

Table 94: Glaucoma – Pipeline by ReNetX Bio, H2 2018

Table 95: Glaucoma – Pipeline by Santen Pharmaceutical Co Ltd, H2 2018

Table 96: Glaucoma – Pipeline by Senju Pharmaceutical Co Ltd, H2 2018

Table 97: Glaucoma – Pipeline by Shire Plc, H2 2018

Table 98: Glaucoma – Pipeline by Sun Pharma Advanced Research Company Ltd, H2 2018

Table 99: Glaucoma – Pipeline by Sylentis SAU, H2 2018

Table 100: Glaucoma – Pipeline by Taejoon Pharm Co Ltd, H2 2018

Table 101: Glaucoma – Pipeline by TikoMed AB, H2 2018

Table 102: Glaucoma – Pipeline by Unity Biotechnology Inc, H2 2018

Table 103: Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) – Pipeline by Alkeus Pharmaceuticals Inc, H2 2018

Table 104: Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) – Pipeline by Bactevo Ltd, H2 2018

Table 105: Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) – Pipeline by Biovista Inc, H2 2018

Table 106: Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) – Pipeline by Fortify Therapeutics Inc, H2 2018

Table 107: Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) – Pipeline by GenSight Biologics SA, H2 2018

Table 108: Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) – Pipeline by Ixchel Pharma LLC, H2 2018

Table 109: Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) – Pipeline by Khondrion BV, H2 2018

Table 110: Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) – Pipeline by Mitobridge Inc, H2 2018

Table 111: Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) – Pipeline by Mitotech SA, H2 2018

Table 112: Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) – Pipeline by Santhera Pharmaceuticals Holding AG, H2 2018

Table 113: Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) – Pipeline by Spark Therapeutics Inc, H2 2018

Table 114: Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) – Pipeline by Stealth BioTherapeutics Inc, H2 2018

Table 115: Optic Neuritis – Pipeline by Bionure Farma SL, H2 2018

Table 116: Optic Neuritis – Pipeline by Commence Bio Inc, H2 2018

Table 117: Optic Neuritis – Pipeline by Lipocure Ltd, H2 2018

Table 118: Optic Neuritis – Pipeline by Meta-IQ ApS, H2 2018

Table 119: Optic Neuritis – Pipeline by Mitochon Pharmaceuticals Inc, H2 2018

Table 120: Optic Neuritis – Pipeline by Teijin Pharma Ltd, H2 2018

Table 121: Optic Neuropathy – Dormant Projects, H2 2018

Table 122: Glaucoma – Dormant Projects, H2 2018

Table 123: Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) – Dormant Projects, H2 2018

Table 124: Optic Neuritis – Dormant Projects, H2 2018

Table 125: Optic Neuropathy – Discontinued Products, H2 2018

Table 126: Glaucoma – Discontinued Products, H2 2018

Table 127: Optic Neuritis – Discontinued Products, H2 2018

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$11985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards